Youko Ikeda
Program: Cancer Therapeutics
Summary
Dr. Ikeda’s research interests focus on furthering the understanding of the various cellular mechanisms that regulate urinary bladder contractile and storage functions, as well as determining the consequences of neurogenic injury, chemical cystitis and ionizing radiation exposure to the lower urinary tract to elucidate novel therapeutic agents. Dr. Ikeda is currently investigating the senotherapeutic actions of soluble guanylate cyclase activators on radiation-induced cell senescence in the urinary bladder and orthotopic prostate tumors. This project is supported by the Hillman developmental pilot award and has since been expanded to a multi-PI R01 submission (R01CA285362) submitted with Dr. Anthony Kanai.